Product
Oral Phosphate Supplement
1 clinical trial
1 indication
Indication
X-Linked HypophosphatemiaClinical trial
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)Status: Completed, Estimated PCD: 2018-02-12